Asthma is a complex, heterogeneous chronic airway disease with high prevalence of uncontrolled disease. New therapies, including biologics, are now available to treat T2 high asthma. Treatment of T2 low asthma remains a challenge. Asthma guidelines need be to updated to incorporate new therapeutics.
- Asthma endotypes
- Bronchial thermoplasty
- Long-acting antimuscarinic agents
- Severe asthma